Jan 5, 2024 | Access solutions, Acquisition Cost Index (ACI), Appropriateness Solutions, Benefits preservation, Comparative Effectiveness, Drug costs, MedBen Rx, Pricing solutions, Specialty Drugs
Pfizer, Sanofi, Takeda Pharmaceutical, and other drugmakers will raise the prices of more than 500 drugs in early January, according to an analysis by health care researchers 3 Axis Advisors. Inflation and rising manufacturing costs will contribute to the price...
Dec 22, 2023 | Acquisition Cost Index (ACI), Cost Plus Pricing, Cost Savings, Drug costs, MedBen Rx, Pharmacies, Prescription drugs, Rx Costs, Savings, Spread Pricing
Spread pricing is the difference between what pharmacy benefit managers (PBMs) charge health plans for drugs and what the pharmacy actually pays for them. Often, this “spread” can be substantial, as PBMs profit greatly from their lack of transparency… so it’s not...
Nov 30, 2021 | 340B, Acquisition Cost Index (ACI), Case Study, Comparative Effectiveness, Health systems, MedBen Rx, Own Use, Pharmacy Benefits Manager (PBM), Prescription drugs, Rx Costs, Rx Spending, Savings
In their first year with MedBen Rx, a regional health system lowered costs by $4.6 million through pharmacy savings and added revenue. This includes a 30% reduction in employee pharmacy plan spend. The health system had previously entered into three-year agreement...
Aug 11, 2019 | Acquisition Cost Index (ACI), MedBen Rx Advocate, Rebates, Rx Costs, Rx Spending
If you’re tired of trying to figure out all of the confusing lingo and mathematics of the pharmaceutical world, MedBen Rx Advocate is for you. Our straightforward approach to pharmacy solutions has been proven to save clients money and the best part is, you only need...
